Cipro Buyers, Barr Reach $225M Deal In Pay-For-Delay Suit
A class of buyers of the antibiotic drug Cipro on Wednesday asked a California court to approve a $225 million settlement with Barr Laboratories Inc. over allegations the company was involved...To view the full article, register now.
Already a subscriber? Click here to view full article